Literature DB >> 19111719

Investigating the risk of hypertension shortly after pregnancies complicated by preeclampsia.

Andrea G Edlow1, Sindhu K Srinivas, Michal A Elovitz.   

Abstract

OBJECTIVE: Women with a history of preeclampsia are at increased risk for long-term cardiovascular morbidity and mortality. This study assessed whether a pregnancy complicated by preeclampsia is associated with an increased prevalence of maternal hypertension and other cardiovascular risk factors shortly after delivery. STUDY
DESIGN: Seventy-nine cases and 140 controls that had been enrolled in a prospective case-control study were evaluated in this planned follow-up analysis. The presence of hypertension, diabetes and dyslipidemia were assessed by standardized questionnaire 6-13 months after delivery.
RESULTS: Women with preeclampsia were significantly more likely than controls to have hypertension (adjusted odds ratio, 13.92; 95% CI, 5.17-37.4; P < .001) after adjusting for confounders. Women with preterm preeclampsia also had an increased odds of hypertension (adjusted odds ratio, 18.31; 95% CI, 5.04-66.46; P < .001) compared with controls.
CONCLUSION: Pregnancy complications, such as preeclampsia, may provide opportunities to identify women at risk for cardiovascular morbidity years before the onset of disease, allowing a window for prevention and intervention.

Entities:  

Mesh:

Year:  2008        PMID: 19111719     DOI: 10.1016/j.ajog.2008.10.012

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

1.  Factors associated with postpartum follow-up and persistent hypertension among women with severe preeclampsia.

Authors:  L D Levine; C Nkonde-Price; M Limaye; S K Srinivas
Journal:  J Perinatol       Date:  2016-09-01       Impact factor: 2.521

Review 2.  Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis.

Authors:  Morven Caroline Brown; Kate Elizabeth Best; Mark Stephen Pearce; Jason Waugh; Stephen Courtenay Robson; Ruth Bell
Journal:  Eur J Epidemiol       Date:  2013-02-09       Impact factor: 8.082

Review 3.  Pregnancy in women with congenital heart disease.

Authors:  Rohan D'Souza; Mathew Sermer; Candice K Silversides
Journal:  Obstet Med       Date:  2015-02-27

4.  Preeclampsia in pregnancy and later use of antihypertensive drugs.

Authors:  Anders Engeland; Tone Bjørge; Kari Klungsøyr; Rolv Skjærven; Svetlana Skurtveit; Kari Furu
Journal:  Eur J Epidemiol       Date:  2015-03-18       Impact factor: 8.082

Review 5.  Adult Congenital Heart Disease with Pregnancy.

Authors:  Koichiro Niwa
Journal:  Korean Circ J       Date:  2018-04       Impact factor: 3.243

Review 6.  Pre-eclampsia is associated with a twofold increase in diabetes: a systematic review and meta-analysis.

Authors:  Pensee Wu; Chun Shing Kwok; Randula Haththotuwa; Rafail A Kotronias; Aswin Babu; Anthony A Fryer; Phyo K Myint; Carolyn A Chew-Graham; Mamas A Mamas
Journal:  Diabetologia       Date:  2016-09-19       Impact factor: 10.122

7.  Postpartum Interventions to Reduce Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: A Systematic Review.

Authors:  Nicla A Lui; Gajana Jeyaram; Amanda Henry
Journal:  Front Cardiovasc Med       Date:  2019-11-15

Review 8.  Hypertensive Disorders of Pregnancy and Future Cardiovascular Health.

Authors:  Karen Melchiorre; Basky Thilaganathan; Veronica Giorgione; Anna Ridder; Alessia Memmo; Asma Khalil
Journal:  Front Cardiovasc Med       Date:  2020-04-15

Review 9.  Use of Race, Ethnicity, and National Origin in Studies Assessing Cardiovascular Risk in Women With a History of Hypertensive Disorders of Pregnancy.

Authors:  Amy Johnston; Victrine Tseung; Sonia R Dancey; Sarah M Visintini; Thais Coutinho; Jodi D Edwards
Journal:  CJC Open       Date:  2021-08-20

Review 10.  Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when.

Authors:  T Katrien J Groenhof; Bas B van Rijn; Arie Franx; Jeanine E Roeters van Lennep; Michiel L Bots; A Titia Lely
Journal:  Eur J Prev Cardiol       Date:  2017-09-12       Impact factor: 7.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.